C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
ABS | ESOT | | | DRUG 2017-1 (USD 150m) | DRI Capital Inc | | USOA | Jun 5, 2017 | | Class | CCY | SIZE (M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | IPT | GDNC | SPRD | CPN | YLD | PRICE |
---|
I1 | ARG | 92.000 | 2.33 | - | BBB | - | - | AAA | - | - | Wbmostxc | 3zS | - | - | 250 | 3vD+250 | - | 358.00000 | M2 | QAJ | 85.000 | 8.96 | - | CCC | - | - | III | - | - | Hifjm | - | - | - | - | 3.60% | 3.625% | 50.30336 |
Tranche Comments I1: Registration: 144Q Zehx;
M2: Registration: 144S Jnko; |
|